Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 07, 2026 09:11 ET | Source: Cellution Biologics

Cellution Biologics Inc. Announces Official Entry into the Ocular Market at ASCRS with the Launch of OptiCover™

Cellution Biologics launches OptiCover™, a shelf-stable amniotic graft with HC-HA/PTX3, at ASCRS to address dry eye and ocular surface repair.